AbbVie, Coherus in legal battle over Humira biosimilar
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
168,120€
2,59%
Echtzeit-Aktienkurs Abbvie Inc.
Bid:
Ask:
Nachrichten zur Abbvie Inc. Aktie
Abbvie, Coherus agree to resolve dispute over Humira biosimilar
...(Reuters) - Coherus BioSciences Inc said on Thursday it had... the licensing agreement.
AbbVie did not…
BEIGENE On Reported Brukinsa Infringement: To React when Appropriate with Vigorous Defense
BEIGENE (06160.HK)'s blood cancer drug "Brukinsa" was purportedly sued for infringement. In response, the company said it will react to…
Ironwood (IRWD), AbbVie Get FDA Nod for Linzess Label Expansion
Ironwood (IRWD) lead drug Linzess gets FDA approval for pediatric functional constipation The label expansion of the drug is expected…
Final Trades: Abbvie, Broadcom, Deere
The "Halftime Report" traders give their top picks to watch for the second half....…
Better Long-Term Buy: AbbVie or Novo Nordisk?
Its important to factor in a pharmaceutical companys pipeline depth....…
Teva, Walgreens, CVS, AbbVie to pay $17.3B in national opioid settlement
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…
AbbVie, Amgen among firms targeted for Medicare inflation penalties
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Is AbbVie or Amgen the Better Bargain Buy Right Now?
These elite drugmakers are both working through a number of headwinds....…
Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Diseases
Funding supports clinical development of first therapeutic candidate and pipeline expansion Marie-Claire Peakman, PhD, Partner, Pfizer Ventures, and Jasmina Marjanovic,…
AbbVie, Amgen hit 52-week lows as Coherus unveils cheapest Humira version
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why AbbVie and Amgen Are Moving Lower Today
An ultra-low-priced biosimilar may negatively impact both biotechs....…
Mark Cuban online pharmacy to offer AbbVie Humira biosimilar
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca halts AbbVie-partnered bowel disease drug program
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie meets key goals for Rinvoq in mid-stage SLE trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study
WASHINGTON (dpa-AFX) - AbbVie Inc. (ABBV), a clinical-stage pharmaceutical company, Wednesday announced the results of its phase 2 SLEek study…
AbbVie Unusual Options Activity
read more...…
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
Should You Pick AbbVie Stock Over LLY?
Looking at stock returns, Eli Lilly has outperformed AbbVie and the broader indices....…
The Zacks Analyst Blog Highlights AbbVie, Intel, Qualcomm, Regeneron and CME Group
AbbVie, Intel, Qualcomm, Regeneron and CME Group are included in this Analyst Blog....…
Top Research Reports for AbbVie, Intel & Qualcomm
Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Intel Corporation (INTC) and Qualcomm…
AbbVie (ABBV) Gets FDA Nod for Lymphoma Drug Epcoritamab
The FDA approves AbbVies (ABBV) epcoritamab, to be marketed as Epkinly, for relapsed/refractory large B-cell lymphoma, a form of NHL.…
AbbVie, Genmab granted FDA nod for lymphoma therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Gets FDA Expanded Nod for Rinvoq in Crohns Disease
AbbVie Gets FDA Expanded Nod for Rinvoq in Crohn's Disease...…
P/E Ratio Insights for AbbVie
read more...…
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
Allergan Aesthetics Says FDA Approves SKINVIVE By JUVEDERM
WASHINGTON (dpa-AFX) - Allergan Aesthetics, an AbbVie company (ABBV), announced Monday the U.S. FDA approval of SKINVIVE by JUVEDERM to…
AbbVie Says Health Canada Approves RINVOQ To Treat Adults With Active Nr-axSpA
OTTAWA (dpa-AFX) - AbbVie (ABBV) announced Tuesday that Health Canada has approved RINVOQ (upadacitinib, 15 mg), the first oral, once-daily…
AbbVie Rinvoq gets approval in Canada for expanded use in axial spondyloarthritis
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Looking for Steady, Passive Income? Buy AbbVie Stock
The drugmaker looks poised to rebound from its Humira loss of exclusivity....…
Form 10-Q AbbVie Inc. For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
2 Things About AbbVie That Investors Are Ignoring
AbbVie shares slipped following the latest earnings report....…
Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVie
One big drugmakers pain translates into another big drugmakers gain....…
AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Where Will AbbVie Be in 5 Years?
AbbVie has been a strong performer since its split from Abbott Labs, and its trying hard to keep the momentum…
AbbVie Stock Plunged: Should You Buy the Dip?
Last weeks sell-off appears to have been overdone....…
Übernahme von Botox-Hersteller gibt AbbVie Schub
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Agentur - Boehringer und AbbVie in Gesprächen über Krebs-Allianz
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…